NASDAQ:RDNT • US7504911022
The current stock price of RDNT is 71.33 USD. Today RDNT is down by -1.72%. In the past month the price increased by 1.74%. In the past year, price increased by 41.78%.
ChartMill assigns a technical rating of 6 / 10 to RDNT. When comparing the yearly performance of all stocks, RDNT is one of the better performing stocks in the market, outperforming 75.07% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to RDNT. While RDNT is still in line with the averages on profitability rating, there are concerns on its financial health.
On March 1, 2026 RDNT reported an EPS of 0.2 and a revenue of 522.87M. The company missed EPS expectations (-12.24% surprise) and beat revenue expectations (3.68% surprise).
14 analysts have analysed RDNT and the average price target is 93.59 USD. This implies a price increase of 31.2% is expected in the next year compared to the current price of 71.33.
For the next year, analysts expect an EPS growth of -43.54% and a revenue growth 10.42% for RDNT
Over the last trailing twelve months RDNT reported a non-GAAP Earnings per Share(EPS) of 0.38. The EPS decreased by -37.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.35% | ||
| ROE | -1.2% | ||
| Debt/Equity | 1.01 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.13 | 102.176B | ||
| CI | THE CIGNA GROUP | 9.11 | 74.804B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 101.3 | 26.595B | ||
| LH | LABCORP HOLDINGS INC | 15.59 | 23.46B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.83 | 23.178B | ||
| GH | GUARDANT HEALTH INC | N/A | 12.021B | ||
| DVA | DAVITA INC | 11.7 | 10.438B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 30.26 | 7.867B | ||
| CHE | CHEMED CORP | 16.95 | 5.841B | ||
| OPCH | OPTION CARE HEALTH INC | 16.11 | 4.881B | ||
| BLLN | BILLIONTOONE INC CL A | 281.38 | 3.805B | ||
| HIMS | HIMS & HERS HEALTH INC | 30.12 | 3.606B |
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company is headquartered in Los Angeles, California and currently employs 8,546 full-time employees. The company went IPO on 2001-12-12. The firm has a network of 407 owned and/or operated outpatient imaging centers. Its Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. Its Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company provides radiology information technology and artificial intelligence (AI) solutions marketed under the DeepHealth brand and teleradiology professional services. The company is also a provider of AI-powered breast health solutions.
RADNET INC
1510 Cotner Ave
Los Angeles CALIFORNIA 90025 US
CEO: Howard G. Berger
Employees: 8546
Phone: 13104787808
RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company is headquartered in Los Angeles, California and currently employs 8,546 full-time employees. The company went IPO on 2001-12-12. The firm has a network of 407 owned and/or operated outpatient imaging centers. Its Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. Its Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company provides radiology information technology and artificial intelligence (AI) solutions marketed under the DeepHealth brand and teleradiology professional services. The company is also a provider of AI-powered breast health solutions.
The current stock price of RDNT is 71.33 USD. The price decreased by -1.72% in the last trading session.
RDNT does not pay a dividend.
RDNT has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
RADNET INC (RDNT) has a market capitalization of 5.52B USD. This makes RDNT a Mid Cap stock.
The outstanding short interest for RADNET INC (RDNT) is 11.58% of its float.